Background Hypertrophic cardiomyopathy (HCM) is characterised by abnormal thickening of ventricular myocardium. Left ventricular outflow tract (LVOT) obstruction occurs in up to 70% of patients, ...
Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...
Stian Lydersen dr.ing. and professor of medical statistics at the Regional Centre for Child and Youth Mental Health and Child Welfare (RKBU Central Norway) at the Department of Mental Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results